Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells

Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype. The high rate of metastasis associated to the fact that these cells frequently display multidrug resistance, make the treatment of metastatic disease difficult. Development of antitumor metal-based drugs was started w...

Descripción completa

Detalles Bibliográficos
Autores principales: Popolin, Cecília P., Reis, João P. B., Becceneri, Amanda B., Graminha, Angélica E., Almeida, Márcio A. P., Corrêa, Rodrigo S., Colina-Vegas, Legna A., Ellena, Javier, Batista, Alzir A., Cominetti, Márcia R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595280/
https://www.ncbi.nlm.nih.gov/pubmed/28898246
http://dx.doi.org/10.1371/journal.pone.0183275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595280/
https://www.ncbi.nlm.nih.gov/pubmed/28898246
http://dx.doi.org/10.1371/journal.pone.0183275

Ejemplares similares